CML

(redirected from chronic myelocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to chronic myelocytic leukemia: myelogenous, chronic granulocytic leukemia

CML

See: Capital market line

Capital Market Line

In the capital asset pricing model, a line that plots the extra return an investor expects for each change in the level of risk. Rational investors expect higher returns for riskier assets and the capital market line shows this graphically. A portfolio that accurately reflects the capital market line is considered a Markowitz efficient portfolio. The slope of the capital market line is a calculation of the equilibrium market price of risk. See also: Beta.
Mentioned in ?
References in periodicals archive ?
The report provides a snapshot of the global therapeutic landscape of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2015
A three way complex translocation (4;9;22) in two patients with chronic myelocytic leukemia.
Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients / Alti kronik miyeloid losemi olgusunda farkli kirik noktali varyant Philadelphia translokasyonlari
It also reviews key players involved in the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia).
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2012
The report provides comprehensive information on the therapeutics under development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016
Key words: Imatinib, chronic myelocytic leukemia, non-Hodgkin's lymphoma
Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib / Imatinib alan bir kronik miyeloid losemi olgusunda gelisen non-Hodgkin lenfoma
An Overview of Pipeline Products for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
Unaccomplished Trials of Chronic Myelocytic Leukemia (CML)
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011
The clinical trial report, Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010" provides data on the Chronic Myelocytic Leukemia (CML) clinical trial scenario.
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trial Review
Chronic Myelocytic Leukemia Pipeline Review, Q4 2010, provides an overview of the Chronic Myelocytic Leukemia therapeutic pipeline.
Research and Markets: Chronic Myelocytic Leukemia (CML) - Pipeline Review, Q4 2010

Financial browser ?
Full browser ?